Abstract
Nipple discharge in breast cancer cases was examined loss of heterozygosity (LOH). DNA samples were extracted from both supernatant and cell pellet components of the discharge, and examined for LOH at microsatellite markers, D11S1818, D11S2000, D16S402, D16S504, D16S518, D17S520, and D17S786. At least one LOH was found in either the supernatant or cell pellet in seven out of 10 patients (70%). Five of seven samples, which were cytologically negative, were LOH positive, and only one case, which was cytologically positive, showed no LOH on the markers examined. All three samples, which were judged ‘negative’ by CEA measurement (<400 ng/ml), were LOH positive. This method could be a useful novel diagnostic modality for nonpalpable breast cancer with nipple discharge.
Similar content being viewed by others
References
Leis HP, Greene FL, Cammarata A, Hilfer S: Nipple discharge: surgical significance. South Med J 81: 20–26, 1988
Seltzer MH: The significance of breast complaints as correlated with age and breast cancer. Am Surg 58: 413–417, 1992
Ohuchi N, Furuta A, Mori S: Management of ductal carcinoma in situ with nipple discharge. Intraductal spreading of carcinoma is an unfavorable pathologic factor for breastconserving surgery. Cancer 74: 1294–1302, 1994
Chaudary MA, Millis RR, Davis GC, Hayward JL: Nipple discharge: the diagnostic value of testing for occult blood. Ann Surg 196: 651–655, 1982
Murad TM, Contesso G, Muriesse H: Nipple discharge from the breast. Ann Surg 195: 259–264, 1982
Van ZK, Ortega PG, Minnard E, Cohen MA: Preoperative galactography increases the diagnostic yield of major duct excision for nipple discharge. Cancer 82: 1874–1880, 1998
Tyler JR, Baird L, Jones T, Kune GA: Cytology: a useful adjunct in the management of nipple discharge. Aust NZ J Surg 52: 610–612, 1982
Dunn JM, Lucarotti ME, Wood SJ, Mumford A, Webb AJ: Exfoliative cytology in the diagnosis of breast disease. Br J Surg 82: 789–791, 1995
Inaji H, Yayoi E, Maeura Y, Matsuura N, Tominaga S, Koyama H, Takatsuka Y, Mori T: Carcinoembryonic antigen estimation in nipple discharge as an adjunctive tool in the diagnosis of early breast cancer. Cancer 60: 3008–3013, 1987
Mori T, et al: Research group for carcinoembryonic antigen in nipple discharge: evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Jpn J Clin Oncol 19: 373–379, 1989
Chaudary MA, Millis RR, Davies GC, Hayward JL: The diagnostic value of testing for occult blood. Ann Surg 196: 651–655, 1982
Ito Y, Tamaki Y, Nakano Y, Kobayashi T, Takdeda T, Wakasugi E, Miyashiro I, Komoike Y, Miyazaki M, Nakayama T, Kano T, Monden M: Nonpalpable breast cancer with nipple discharge: how should it be treated. Anticancer Res 17: 791–794, 1997
Wilentz RE, Chung CH, Sturm PD, Musler A, Sohn TA, Offerhaus GJ, Yeo CJ, Hruban RH, Slebos RJ: K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Cancer 82: 96–103, 1998
Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, Lederrey C, Anker P: Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 2:1033–1035, 1996
Nawroz H, Koch W, Anker P, Stroun M, Sidransky D: Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 2: 1035–1037, 1996
Fujiwara Y, Chin DJ, Wang H, Kaleman P, Morton DL, Tutner R, Hoon DSB: Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients. Cancer Res 59: 1999 (in press)
Motomura K, Koyama H, Noguchi S, Inaji H, Azuma C: Detection of c-erB-2 gene amplification in nipple discharge by means of polymerase chain reaction. Breast Cancer Res Treat 33: 89–92, 1994
Stroun M, Anker P, Lyautey J, Lederrey C, Maurice PA: Isolation and characterization of DNA from the plasma of cancer patients. Eur J Cancer Clin Oncol 23: 707–712, 1987
Stroun M, Anker P, Maurice P. Lyautey J, Lederrey C, Beljanski M: Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46: 318–322, 1989
Bieche I, Lidereau R: Genetic alterations in breast cancer. Genes Chromo Cancer 14: 227–251, 1995
Aldaz CM, Chen T, Sahin A, Cunningham J, Bondy M: Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas. Cancer Res 55: 3976–3981, 1995
Munn KE, Walker RA, Varley JM: Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast. Oncogene 10: 1653–1657, 1995
Laake K, Odegard A, Andersen TI, Bukholm 1K, Karesen R, Nesland JM, Ottestad L, Shiloh Y, Borresen DA: Loss of heterozygosity at 11q23. 1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Genes Chromo Cancer 18: 175–180, 1997
Marsh KL, Varley JM: Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast. Br J Cancer 77: 1439–1447, 1998
Negrini M, Rasio D, Hampton GM, Sabbioni S, Rattan S, Carter SL, Rosenberg AL, Schwartz GF, Shiloh Y, Cavenee WK, Croce KM: Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. Cancer Res 55: 3003–3007, 1995
Radford DM, Fair KL, Phillips NJ, Ritter JH, Steinbrueck T, Holt MS. Donis KH: Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. Cancer Res 55: 3399–3405, 1995
Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G, Nakamura Y: Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 50: 7184–7189, 1990
Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS: Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274: 2057–2059, 1996
Fujii H, Szumel R, Marsh C, Zhou W, Gabrielson B: Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast. Cancer Res 56: 5260–5265, 1996
Chen T, Sahin A, Aldaz CM: Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region. Cancer Res 56: 5605–5609, 1996
Chuaqui RF, Zhuang Z, Emmett BM, Liotta LA, Memo MJ: Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. Am J Pathol 150: 297–303, 1997
Lininger RA, Park WS, Man YG, Pham T, MacGrogan G, Zhuang Z, Tavassoli FA: LOH at l6p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast. Hum Pathol 29: 1113–1118, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miyazaki, M., Tamaki, Y., Sakita, I. et al. Detection of microsatellite alterations in nipple discharge accompanied by breast cancer. Breast Cancer Res Treat 60, 35–41 (2000). https://doi.org/10.1023/A:1006336110322
Issue Date:
DOI: https://doi.org/10.1023/A:1006336110322